January 15, 2021
1 min read
Save
AFFIRM-AHF
Issue: January 2021

Ferric carboxymaltose vs. placebo in iron-deficient patients with acute HF.
Ferric carboxymaltose vs. placebo in iron-deficient patients with acute HF.